Germ cells are responsible for the transmission of genetic and epigenetic information across generations. At present, the number of infertile couples is increasing worldwide; these infertility problems can be traced to environmental pollutions, infectious diseases, cancer, psychological or work-related stress, and other factors, such as lifestyle and genetics. Notably, lack of germ cells and germ cell loss present real obstacles in infertility treatment. Recent research aimed at producing gametes through artificial germ cell generation from stem cells may offer great hope for affected couples to treat infertility in the future. Therefore, this rapidly emerging area of artificial germ cell generation from nongermline cells has gained considerable attention from basic and clinical research in the fields of stem cell biology, developmental biology, and reproductive biology. Here, we review the state of the art in artificial germ cell generation.
INTRODUCTION
Successful sexual reproduction will be essential for the continuity of the human race. However, infertility affects 15%-25% of couples of reproductive age [1, 2] . Evidence is increasing that the quality and quantity of germ cells produced by both men and women have declined over the past two decades due to myriad genetic [3, 4] and environmental causes [5, 6] . The advent of in vitro fertilization and other assisted reproductive techniques has helped infertile couples to parent their own children [7] ; however, nearly 10% of couples are still unable to have children due to a complete lack of germ cells [8] . Although infertility by itself may not threaten affected couples' physical health, it may lead to serious declines in social well-being [9] .
Stem cells are a class of undifferentiated cells that have the unique ability to self-renew and differentiate into specialized cell types. The potential for using stem cells to produce new tissues or repair damaged tissues has largely spurred the currently recognized field of regenerative medicine. Stem cells are categorized by their differentiation potential, with the full classification including totipotent, pluripotent, multipotent, oligopotent, and unipotent [10] . Generally, embryonic stem cells (ESCs) and the newly found induced pluripotent stem cells (iPSCs) [11, 12] are considered to be pluripotent because they have the ability to differentiate into most known embryonic and adult cell lineages. Stem cell niches provide microenvironments that maintain stem cells in an undifferentiated state, which supports their self-renewal by blocking differentiation signals. Moreover, tissue-specific signals emanating from the niche not only support self-renewal of stem cells occupying a given niche but also redirect the fate of early differentiating progenitor cells back into a stem cell state [13, 14] .
Mammalian germ cell lineages begin with primordial germ cells (PGCs), which generate spermatozoa and oocytes in suitable microenvironments provided by the male and female gonads, respectively. Based on the potential of pluripotent stem cells to generate embryonic lineages, including to the germline, many researchers have recently developed strategies to generate germ cells from pluripotent stem cells in vitro (Fig.  1) . Subsequently, artificial germ cells generated from nonpluripotent stem cells, such as somatic stem cells, have been reported. These approaches may offer us clues to understand the basic biology of gametogenesis, which holds the potential to open new avenues for treating or curing human infertility. In this review, we discuss historical studies to the most recent advancements in the generation of germ cells using embryonic and nonembryonic stem cells.
GERM CELL DERIVATION STRATEGIES AND PLAT-FORMS
To date, several different strategies are available for deriving gamete-like cells from stem cells in culture: 1) spontaneous differentiation, 2) differentiation in conditioned medium from somatic cells and/or coculture with somatic cells in medium supplemented with defined growth factors, 3) genetic manipulation, and 4) niche reprogramming ( Fig. 2A) .
Based on factors known to regulate sex determination, germ cell development, and pluripotent stem cell differentiation, systems for monitoring artificial germ cell development from FIG. 1. Schematic representation of artificial germ cell generation. Under appropriate differentiation procedure, ESCs (originated from the inner cell mass of blastocysts), iPSCs (derived from somatic cell reprogramming), EpiSCs ([epiblast stem cells] derived from postimplantation late epiblasts), SSCs (subpopulation of type A spermatogonia), and FGSCs (GSCs for oocyte production) can be used for artificial germ cell generation. Germline-derived ESlike cells could be converted from GSCs (SSC and FGSCs) in vitro; then, the artificial germ cells would be derived following the pluripotent stem cell differentiation protocol. In vivo microenvironments provide structural cues that are crucial for tissue maintenance and function. Thus, newly found techniques, including gonad architecture reconstruction from differentiated progenitors of germ-like cells and in vitro reconstitution of the multistepped germ cell lineage specification pathway, will be helpful for functional artificial germ cell generation in vitro. ZENG ET AL. pluripotent cell lines have been explored using vital markers expressed under control of germline-restricted reporter genes (i.e., green fluorescent protein [GFP] under the control of germ cell specific promoters). The Mvh-Venus/GFP [15, 16] , Stella-GFP [17] , and Acr/Gsg2-GFP [18] reporters have been applied in such studies to visualize and sort out in vitro-derived germ cells. Moreover, signaling molecules, such as bone morphogenetic protein (BMP) 4 [19] , WNT3A [20] , and retinoic acid [21] have been identified as key factors responsible for deriving the induction of pluripotent stem cells into germ cell precursors.
Previous studies have already demonstrated that neonatal mouse testicular architecture can be reconstructed in the subcutis of nude mice [22] [23] [24] [25] , and development of functional germ cells has been reported. Importantly, using the gas-liquid interphase organ culture method, it has been convincingly demonstrated that functional sperm can be generated in vitro [26] [27] [28] and within spontaneously reconstructed epithelium from immature testicular cells [29] . Therefore, organ culture is becoming a useful platform for research associated with gametogenesis and could potentially be refined for artificial germ cell generation from accessible cell sources.
GERM CELL DIFFERENTIATION FROM SOMATIC STEM CELLS
Immunologic and genetic issues are primary challenges of stem cell-based therapeutic approaches and are important to consider in artificial germ cell generation. Fortunately, derivation of autologous stem cells will open new avenues for generating immunocompatible artificial germ cells (Fig. 1) . Some evidence has shown that germ-like cells can be generated from somatic stem cells derived from mouse [30, 31] , sheep [32, 33] , or human [34] [35] [36] mesenchymal stem cells; fetal mouse skin [37, 38] as well as porcine skin [39] [40] [41] [42] or muscle [42, 43] stem cells; and human amniotic fluid stem cells [44, 45] . Combined, these studies provide examples in which somatic stem cells differentiated into male or female germ cells in culture. Although these presumptive germ cells expressed germ cell-related markers, they did not progress beyond the early stages of germ cell development, even after transplantation into the testis or ovaries. Thus, research on artificial germ cell generation directly from adult somatic stem cells is far from being optimized.
GERM CELL DIFFERENTIATION FROM GERMLINE STEM CELLS
In mammals, the germline is unique because it is the only cell lineage that undergoes cell division of two types, mitosis and meiosis, as a requisite for forming haploid gametes. The general developmental steps in gametogenesis for production of sperm or eggs are largely elucidated. Moreover, germline stem cell (GSC) lines may become more suitable for artificial germ cell generation under appropriate culture conditions because sperm and eggs can develop from GSC lines (Fig. 1) . Recently, new evidence demonstrated that female GSCs (FGSCs) isolated from mouse [46] [47] [48] [49] , rat [50] , human [48, 49] , and pig [51] could generate viable offspring or differentiate into oocytes in vivo. Additionally, mouse FGSCs cultured in vitro can differentiate into oocyte-like cells [52] mediated by BMP4 signaling [53] . Although these newly found GSCs hold great potential for artificial oocyte production in vitro, support for the traditional view (i.e., no postnatal follicular renewal occurs in mammals) still exists. Lei and Spradling [54] concluded that adult mouse ovaries lack stem cells after they failed to detect ''germline cysts'' using a lineage tracing approach, and Zhang et al. [55] failed to get mitotically active female germline progenitors from postnatal mouse ovaries. However, as Bhartiya et al. [56] suggested, absence of evidence is not necessarily the evidence of absence. No matter what the various opinions on FGSC, extensive collaborations from different labs supporting the evidence for and against FGSC in mammals should be carried out to address these issues, and many other problems also need to be solved. These include more specific FGSC marker analysis, more efficient isolation and purification protocols, culture condition optimization, stronger lineage tracing studies, and elucidation of the signaling pathways driving FGSC differentiation in vivo. More importantly, it remains to be determined if oocyte-like cells differentiated from FGSCs in vitro maintain the capacity for fertilization with sperm. Likewise, roles for FGSCs in oogenesis, menopause, and even ovarian-related disease remain to be determined.
As the other gender of GSCs, spermatogonial stem cells (SSCs) in testes have been widely studied. Still, in vitro spermatogenesis in mammals has only been reported by one group [57] . It should be noted that the presumptive SSCs from that study were ''experimentally immortalized,'' and similar studies have yet to be performed by other laboratories. Thus, unmodified SSCs are still difficult to differentiate into haploid gametes in vitro. Although some studies have shown that SSCs could support spermatogenesis and then differentiate into functional sperm using seminiferous tubule transplantation and organ culture (standard gas-liquid interphase method) in vitro [18, [58] [59] [60] , such protocols are still complex and difficult to perform. Interestingly, other three-dimensional (3D) in vitro culture systems using two different matrices (soft agar and methylcellulose) reveal the potential for artificial germ cell generation [61, 62] . A new report has shown that mouse male SSCs can be converted into oocyte-like cells in culture [63] , but whether the FGSCs can be converted into spermatogenic cells is still unknown.
It should be stressed that almost all of the artificial or presumptive germ-like cells reported in this review have not resulted in robust, reproducible protocols for deriving gametes, much less approached the gold standard of demonstrating the capacity to produce healthy offspring by fertilization [2] . A major problem in the field is that conventional techniques used for presumptive germ cell identification often lead investigators down incorrect paths due to false positives generated by 1) PCR marker analysis (caused by cell preparation and/or genotyping sample contamination or by misleading pseudogene or retrogene detection), 2) antibody labeling artifacts/ nonspecific signals, and 3) subjective gating/thresholding to analyze DNA content.
GERM CELL GENERATION FROM PLURIPOTENT STEM CELLS
Steady progress has been made in the generation of germ cells from pluripotent ESCs or iPSCs (Fig. 1) .
Germ Cells Differentiated from ESCs
In mice, the first evidence of germ cell generation from ESCs was provided by Hubner et al. [64] . They found that mouse ESCs (mESCs; both XX and XY chromosomes) tagged by Oct4-GFP in the absence of feeder cells and added growth factors condition spontaneously and differentiate into presumptive oocyte-like cells, which not only coexpress oocytespecific markers (SCP3, ZP2, and ZP3) but also form folliclelike structures. Interestingly, these putative oocytes could even develop into blastocyst-like structures via subsequent parthe-ARTIFICIAL GERM CELL GENERATION FROM STEM CELLS nogenic activation. Toyooka et al. [19] found that mESCs could be induced into Mvh-GFP-positive and/or Mvh-lacZpositive cells via embryoid body (EB) differentiation or coculture with somatic cells expressing BMP4. The flowsorted Mvh-postive cells could participate in spermatogenesis in vivo after transplantation into host testis; however, spermatozoa produced were not tested for fertility. Geijsen et al. [65] and West et al. [66] then described haploid gametes generated from ESC differentiation that were competent to form blastocysts following injection into oocytes. Another study showed that oocyte-like cells could be derived from mESCs with XY chromosomes when cultured in conditioned medium collected from testes of newborn male mice [67] . Meiotic progression of germ-like cells were reportedly derived in vitro from mouse and human pluripotent cell lines (ESCs and iPSCs) by ectopic expression of germ cell-specific or meiosis-related proteins, including DAZ [68, 69] , DAZL [68] [69] [70] [71] , BOULE [68, 69] , DDX4 [71] , and GASZ [72] .
Although these studies have suggested that mESCs can differentiate into female and male germ cells in vitro, the differentiation strategies employed were complex, inefficient, and differed substantially among the respective laboratories. It remains to be determined if germ-like cells generated from pluripotent stem cell lines by such approaches are capable of generating offspring. This breakthrough was provided by Nayernia et al. [73] , who demonstrated the birth of live offspring from mESC-derived sperm-like cells. They used a dual fluorescent reporter system (Stra8-driven GFP reporter and Prm1-driven DsRed reporter) to track the progression of mESC-derived germ cells during their derivation process. Cells with sperm-like characteristics were isolated by fluorescenceactivated cell sorting and then injected into mouse oocytes that developed into live offspring. There have been many attempts (Table 1) using different approaches to allow germ-like cells to progress into or complete meiosis. However, several groups [74, 75] have reported that germ-like cells derived from ESCs fail to progress through meiosis appropriately.
Germ cell derivation from cynomolgus monkey ESCs [76, 77] and human ESCs (hESCs) is also being rigorously investigated [78] . In one approach, hESCs were differentiated into germ-like cells using a 3D coculture system based on calcium alginate encapsulation of the ESCs with testicular somatic cells [79] . Although germline-specific markers were clearly expressed by primate cells derived in these systems, functional assays for testing successful generation of human artificial germ cells are largely lacking.
Germ Cells Differentiated from iPSCs
Despite ethical issues centered on germ cell derivation from pluripotent stem cell lines in culture [80] , iPSC technology holds tremendous potential for generating patient-specific artificial gametes. Studies reporting that male hESCs and human iPSCs (hiPSCs) can be differentiated into haploid spermatogenic cells in culture have achieved two significant endpoints: artificial generation of adult-type spermatogonia and postmeiotic round spermatids [81] . However, it remains unknown whether these haploid cells are functional. Proofof-concept for these studies is provided by recent breakthroughs demonstrating the germ cell differentiation potential of iPSCs by Saitou's group. First, male (XY) mESCs and iPSCs bearing Prdm1-mVenus and DPPa3-ECFP (BVSC) reporters were induced into epiblast-like cells (EpiLCs) [82, 83] and then further into PGC-like cells (PGCLCs), which differentiated into viable spermatozoa in recipient mice that were able to generate healthy offspring [84] . Next, to determine whether their reconstitution strategy could be translated to oocyte production, female ESCs and iPSCs expressing BVSC transgenes were induced into EpiLCs and then further into PGCLCs via a differentiation pathway similar to that in males, followed by aggregation with embryonic gonadal somatic cells as in vitro. The PGCLCs underwent oogenesis, including Xreactivation, imprint erasure, cyst formation, and meiosis, after the reconstituted ovarian cells were transplanted under adult mouse ovarian bursa. Functional germinal vesicle oocytes were generated from PGCLCs in up to 1 mo but displayed some differences from normal oocytes, including abnormal elliptical shape at a higher frequency, and a subset of them failed to extrude the second polar bodies. The PGCLC-derived oocytes were matured into eggs in vitro and then contributed to healthy and fertile offspring after fertilization with spermatozoa [85, 86] . These results demonstrated that mESCs and iPSCs could be used for reconstituting the entire processes of spermatogenesis and oogenesis, which might provide the long-sought-after foundation for studying mammalian gametogenesis in vitro. Recently, Nakaki et al. [87] reported a refined strategy for mouse germ cell reconstitution that did not depend on a cocktail of added cytokines; rather, expression of transcription factors (Blimp1, Prdm14, and Tfap2c) in EpiLCs was sufficient to induce PGCLCs development that could further contribute to spermatozoon production and healthy offspring.
GERM CELL GENERATION FROM NICHE REPRO-GRAMMING
Gametogenesis is regulated by ovarian and testicular microenvironments that develop specialized cell-cell and growth factor interactions (nonstem and stem cells), or niches. Therefore, generation of germ cells from stem cells in vitro may likewise require complex niches, including appropriate hormones (endocrine and paracrine), extracellular matrix architecture, and other environmental factors.
Durruthy Durruthy et al. [88] reported that undifferentiated hiPSCs derived from mRNA-based reprogramming with OSKM (OCT3/4, SOX2, KLF4, and cMYC) or OSKMV (OSKM plus a germ cell-specific marker, VASA) factors could directly differentiate into germ cells after transplantation into the seminiferous tubules of germ cell-depleted immunodeficient mice. Significantly, the OSKMV-based iPSCs did not form tumors, whereas the OSKM-based iPSCs that remained outside the seminiferous tubule did. The same group also found that hESCs and azoospermia factor (AZF)-deleted hiPSCs inside murine seminiferous tubules could receive critical molecular cues directing germline differentiation; however, outside seminiferous tubules, AZF-deleted iPSCs maintained their undifferentiated state and formed tumors [89] . Thus, these studies suggest that niche cells, potentially Sertoli cells, are critical to suppress somatic cell differentiation and favor the germline fate in hiPSCs.
CONCLUSIONS AND PERSPECTIVES
Complete restoration of gametogenesis in culture will be important to our understanding of biological events at the cellular and molecular levels that are important for germline development. Understanding these processes will have an enormous impact on applications in the biomedical and agricultural communities. The studies mentioned above suggest that artificial or in vitro-differentiated germ cells could be readily derived from stem cells, including somatic, germline, and pluripotent stem cells.
Significantly, without any gene delivery, unipotent SSCs from mouse [90] [91] [92] [93] [94] and human [95, 96] can convert into an ZENG ET AL. 
ARTIFICIAL GERM CELL GENERATION FROM STEM CELLS ESC-like state in vitro, called germline-derived ES-like cells (gESLCs), which have the same potential as ESCs to differentiate into haploid male gametes [97] . Importantly, FGSCs share many similar characteristics with SSCs [98, 99] , whereas a recent report shows that FGSCs can be converted into pluripotent stem cells similar to those of SSC conversion [100] . Thus, in theory, these female germline-derived pluripotent stem cells should have ability to differentiate back into germ cells. These studies suggest not only that gESLCs may be used for germ cell derivation in vitro (Fig. 1 ), but also that germ cell generation from the gESLC differentiation system provides a unique platform to dissect cellular and developmental mechanisms underlying gametogenesis. This platform may help us find new approaches to treat sex reversalassociated disease. Today, evidence is accumulating that somatic cells can be transdifferentiated into other cell types without acquiring a pluripotent state [101, 102] ; however, whether the somatic cells can directly transdifferentiate into spermatocytes or oocytes by ectopic expression of germline-specific transcription factors is unknown (Fig. 2B) . Additionally, the combination of niche reprogramming and newly found 3D printing techniques [103] may be useful for stem cell-based artificial germ cell generation.
Several problems remain to be solved before artificial germ cells can be applied for treating infertility. These include efficient and highly reproducible protocols for in vitro derivation of genetically and epigenetically healthy, patientspecific gametes from stem cells. Health status of such artificially generated germ cells could theoretically be diagnosed with markers on genome-wide levels (i.e., epigenome, transcriptome, proteome, and metabolome). Once these standards-and any additional safety and ethical standardsare surpassed, clinical application of artificially generated human gametes may someday be warranted for the purpose of treating relevant infertility cases. ZENG ET AL.
